HIV Diagnosis Market by CD4 Count, Test Type (Antibody (Western Blot, ELISA, Rapid), Viral Identification, Early Infant, Viral Load, Product (Kit, Reagent, Instrument, Assay, Software, Services), End User – 2021 to 2026

$3,850.00$5,850.00

Published on: March 23, 2021
Clear
SKU: GMS3013 Category:

OVERVIEW

Amid the COVID-19 outbreak, the market for HIV diagnosis is expected to grow at a CAGR of 8.9%. Factors such as the growing global prevalence of HIV / AIDS, the rising number of blood transfusions and blood donations, the benefits provided by point-of-care devices and kits, and increased policy measures are expected to drive market growth worldwide. In the following report, the impact of the COVID-19 outbreak on the industry will be fully assessed. The reports also compares the markets of Pre COVID-19 and Post COVID-19.

HIV Diagnosis Market by CD4 Count, Test Type (Antibody (Western Blot, ELISA, Rapid), Viral Identification, Early Infant, Viral Load, Product (Kit, Reagent, Instrument, Assay, Software, Services), End User - 2021 to 2026 1

HIV Diagnosis Market by CD4 Count, Test Type (Antibody (Western Blot, ELISA, Rapid), Viral Identification, Early Infant, Viral Load, Product (Kit, Reagent, Instrument, Assay, Software, Services), End User - 2021 to 2026 2

HIV Diagnosis Market by CD4 Count, Test Type (Antibody (Western Blot, ELISA, Rapid), Viral Identification, Early Infant, Viral Load, Product (Kit, Reagent, Instrument, Assay, Software, Services), End User - 2021 to 2026 3

HIV Diagnosis Market by CD4 Count, Test Type (Antibody (Western Blot, ELISA, Rapid), Viral Identification, Early Infant, Viral Load, Product (Kit, Reagent, Instrument, Assay, Software, Services), End User - 2021 to 2026 4

HIV Diagnosis Market by CD4 Count, Test Type (Antibody (Western Blot, ELISA, Rapid), Viral Identification, Early Infant, Viral Load, Product (Kit, Reagent, Instrument, Assay, Software, Services), End User - 2021 to 2026 5

HIV Diagnosis Market by CD4 Count, Test Type (Antibody (Western Blot, ELISA, Rapid), Viral Identification, Early Infant, Viral Load, Product (Kit, Reagent, Instrument, Assay, Software, Services), End User - 2021 to 2026 6

HIV Diagnosis Market by CD4 Count, Test Type (Antibody (Western Blot, ELISA, Rapid), Viral Identification, Early Infant, Viral Load, Product (Kit, Reagent, Instrument, Assay, Software, Services), End User - 2021 to 2026 7

HIV Diagnosis Market by CD4 Count, Test Type (Antibody (Western Blot, ELISA, Rapid), Viral Identification, Early Infant, Viral Load, Product (Kit, Reagent, Instrument, Assay, Software, Services), End User - 2021 to 2026 8

TABLE OF CONTENT

1 Global HIV Diagnosis Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global HIV Diagnosis Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global HIV Diagnosis Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global HIV Diagnosis Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global HIV Diagnosis Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global HIV Diagnosis Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global HIV Diagnosis Market – By Product (Market Size – & million/billion)
8.1 Consumables
8.2 Instruments
8.3 Software & Services

9 Global HIV Diagnosis Market – By Test Type
9.1 Antibody Tests
9.2 Viral Load Tests
9.3 CD4 Tests
9.4 Tests for Early Infant Diagnosis
9.5 Tests for Viral Identification

10 Global HIV Diagnosis Market – By End-User
10.1 Diagnostic Laboratories
10.2 Hospitals
10.3 Blood Banks
10.4 Home Care Settings
10.5 Other

11 Global HIV Diagnosis Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global HIV Diagnosis Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global HIV Diagnosis Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Siemens Healthineers (A Division of Siemens AG)
13.3 Roche Diagnostics (Division of Hoffman La Roche Ltd.)
13.4 Merck KGaA
13.5 Becton, Dickinson & Company
13.6 Abbott Laboratories
13.7 Hologic Inc.
13.8 Alere Inc.
13.9 Bio-Rad Laboratories
13.10 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
13.11 Thermo-Fisher Scientific Inc.
13.12 Company 11 & more

14 Global HIV Diagnosis Market – Appendix
14.1 Sources
14.2 Abbreviations